OGT-mediated O-GlcNAcylation of BICD2 drives gemcitabine resistance in pancreatic cancer via accelerating G2/M cell cycle progression

Drug Resistance Updates · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles